Glaxo Pursues Needle-Free Vaccines - WSJ.com

[Guest guest]

"

GlaxoKline PLC struck a deal with an Austrian firm to develop

needle-free vaccines delivered through a patch, a technology that could

broaden vaccine use by eliminating irksome needle jabs and the need for

vaccine to be refrigerated.

Glaxo, based in Brentford, England, said it will make an initial payment

of €33.6 million ($46 million) to Vienna-based Intercell AG to gain

access to both the patch technology and the marketing rights to

experimental patch vaccines for traveler's diarrhoea and pandemic flu

....

The company's pandemic flu vaccine involves a shot and a patch, and is in

mid-stage human testing. A vaccine against the H5N1 virus that causes

bird flu is delivered through a shot, and then a patch containing a

booster ingredient is placed on the skin for six hours. The booster,

called an adjuvant, is meant to make the shot more

effective. "

READ THE FULL ARTICLE

http://online.wsj.com/article/SB10001424052748704517504574589952804137702.html?mod=europe_home

Sheri Nakken, R.N., MA, Hahnemannian

Homeopath

Vaccination Information & Choice Network, Washington State, USA

Vaccines -

http://www.nccn.net/~wwithin/vaccine.htm or

http://www.wellwithin1.com/vaccine.htm

Vaccine Dangers, Childhood Disease Classes & Homeopathy

Online/email courses - next classes start January 6 & 7

http://www.wellwithin1.com/vaccineclass.htm or

http://www.wellwithin1.com/homeo.htm